雪榕生物：8月26日召开董事会会议

Group 1 - The core point of the article is that Xuerong Biotechnology (SZ 300511) held its 31st meeting of the 5th Board of Directors on August 26, 2025, to review the semi-annual report and its summary for 2025 [1] - For the year 2024, Xuerong Biotechnology's revenue composition shows that the edible mushroom industry accounts for 98.62%, while other businesses contribute 1.38% [1] Group 2 - The pet industry is experiencing significant growth, with a market size of 300 billion yuan, leading to a surge in stock prices for related listed companies [1]